OTHER · Unmapped registry intervention
Cardiac Magnetic Resonance Imaging (CMR)
Find medicine records ·
Find other trials using this name
Clinical trial
Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer
NCT02666378
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
Echocardiogram (ECHO)
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedImaging Markers of Subclinical Cardiotoxicity in Breast Cancer
Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Interventions
Sponsors & collaborators
Beth Israel Deaconess Medical Centerlead sponsor
American Heart Associationcollaborator
Dana-Farber Cancer Institutecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02666378 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.